Jeeyun Lee
Clinical trials sponsored by Jeeyun Lee, explained in plain language.
-
New drug duo aims to fight tough stomach cancers
Disease control Recruiting nowThis study is testing whether combining two existing cancer drugs works better than current treatments for advanced stomach cancer that has a low level of a protein called HER2. The trial will enroll about 61 adults whose cancer has worsened after one or two prior treatments. Res…
Phase: PHASE1, PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test powerful drug combo to shrink tough stomach tumors before surgery
Disease control Recruiting nowThis study is testing whether a combination of targeted cancer drugs can shrink tumors in patients with advanced stomach cancer that cannot be removed by surgery right away. The goal is to see if giving these drugs before and after surgery can better control the cancer. The trial…
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New drug duo targets tough stomach cancers
Disease control Recruiting nowThis study is testing whether combining two drugs, savolitinib and durvalumab, can help control advanced stomach cancer that has a specific genetic feature (MET amplification) and has worsened after initial chemotherapy. The goal is to see if this combination can slow or stop the…
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC